Abstract
The chemical composition of traditional Chinese medicine (TCM) is inordinately complex; therefore, it is a daunting task to reflect on its integrity and methodology by means of adopting the reductionist philosophy of western medicine. It cannot quintessentially manifest the scientific nature of TCM. The augmentation of modern scientific research and the introduction of network pharmacology have gradually transformed the research idea of single component and single target to the overall regulation of a complex system. Network pharmacology studies problems from the perspective of interrelation, which coincides with the core holistic view of Chinese medicine. Therefore, the application of network pharmacology in the study of TCM has unique advantages, and is conducive to a thorough understanding of the value and significance of the overall view of TCM. Several related studies have also emerged. In this chapter, single medicinal components and compound preparations are taken as examples to demonstrate the commonly used drug-disease-based network pharmacology analysis methods from two research examples.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chen Y, Wu H, Nie YC, et al. Mucoactive effects of naringin in lipopolysaccharide-induced acute lung injury mice and beagle dogs. Environ Toxicol Pharmacol. 2014;38(1):279–87.
Liu Y, Wu H, Nie YC, et al. Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-kappa B pathway. Int Immunopharmacol. 2011;11(10):1606–12.
Nie YC, Wu H, Li PB, et al. Anti-inflammatory effects of naringin in chronic pulmonary neutrophilic inflammation in cigarette smoke-exposed rats. J Med Food. 2012;15(10):894–900.
Liu MH, Zou W, Yang CP, et al. Metabolism and excretion studies of oral administered naringin, a putative antitussive, in rats and dogs. Biopharm Drug Dispos. 2012;33:123–34.
Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57.
Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1–13.
Ransom RF, Lam NG, Hallett MA, et al. Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int. 2005;68(6):2473–83.
Zhang H, Ma SF, Feng ZW, et al. Cardiovascular disease chemogenomics knowledgebase-guided target identification and drug synergy mechanism study of an herbal formula. Sci Rep. 2016;6:33963.
Liu H, Zhang WJ, Long CF, et al. Protective effects of traditional Chinese herbal formula compound xueshuantong capsule (CXC) on rats with blood circulation disorders. Biotechnol Biotechnol Equip. 2017;31(4):1–9.
Dusting GJ, Selemidis S, Jiang F. Mechanisms for suppressing NADPH oxidase in the vascular wall. Mem Inst Oswaldo Cruz. 2005;100(1):97.
Li S. Mapping ancient remedies: applying a network approach to traditional Chinese medicine. Science. 2015;350:S72–4.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Su, W., Li, P. (2021). Drug-Disease-Based Network Pharmacology Practice Process. In: Li, S. (eds) Network Pharmacology. Springer, Singapore. https://doi.org/10.1007/978-981-16-0753-0_9
Download citation
DOI: https://doi.org/10.1007/978-981-16-0753-0_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-0752-3
Online ISBN: 978-981-16-0753-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)